Earnings · China A-shares
Hunan Dajiaweikang Pharmaceutical Industry Co., Ltd. Class A (301126) earnings
Hunan Dajiaweikang Pharmaceutical Industry Co., Ltd. Class A published its Q3 report on 2026-10-22: net profit +91.98% year on year, +170.68% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -4.72% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-22
- Period end
- 2026-09-30
- Net profit YoY
- +91.98%
- Excl. one-offs YoY
- +170.68%
- Net profit QoQ
- +95.85%
- Result
- Great
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -1.39% | — |
| 3 days | -4.72% | — |
| 7 days | -6.32% | — |
| 14 days | -3.22% | — |
Report history
Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 3 of 6 reports (average -0.38%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-23 | ¥9.79M | +91.98% | +170.68% | -2.24% | 0.05 | 0.62% | -4.72% | — | — |
| 2026 interim report | 2026-08-29 | ¥7.26M | +712.11% | +1269.15% | -0.25% | 0.04 | 0.44% | +0.87% | -6.28% | +3.05% |
| 2026 Q1 report | 2026-04-28 | ¥5.96M | +89.70% | +466.15% | +6.49% | 0.03 | 0.40% | +4.48% | -16.08% | -15.46% |
| 2025 annual report | 2026-04-28 | -¥242.46M | -1012.36% | — | -1.70% | -1.18 | -14.91% | +4.48% | -16.08% | -15.46% |
| 2025 Q3 report | 2025-10-28 | ¥5.10M | -86.02% | -89.02% | +3.69% | 0.03 | 0.29% | -2.15% | +12.05% | +15.42% |
| 2025 interim report | 2025-08-29 | ¥893.53K | -97.19% | — | +4.16% | 0.00 | 0.05% | +0.08% | -4.44% | -5.72% |
| 2025 Q1 report | 2025-04-21 | ¥3.14M | -83.82% | -94.84% | +1.51% | 0.02 | 0.18% | -0.86% | +5.56% | +2.61% |
| 2024 annual report | 2025-04-21 | ¥26.57M | -22.52% | -25.40% | +34.07% | 0.13 | 1.52% | -0.86% | +5.56% | +2.61% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.